Icon PLC (ICLR): Net Income
$229.34M
Year ended 2025-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $229.34M | -69.0% | 2026-05-27, From 2025-01-01 |
| 2024-12-31 | $739.13M | +33.4% | 2026-05-27, From 2024-01-01 |
| 2023-12-31 | $554.21M | n/c | 2026-05-27, From 2023-01-01 |
| 2022-12-31 | $505.30M | +229.9% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $153.19M | -53.9% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $332.33M | -11.1% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $373.99M | +15.9% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $322.66M | +14.6% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $281.49M | +7.4% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $262.18M | +9.5% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $239.54M | +38.9% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $172.47M | +67.8% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $102.81M | +85.5% | 2016-03-23, From 2013-01-01 |
| 2012-12-31 | $55.42M | +142.2% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $22.88M | -73.7% | 2014-03-12, From 2011-01-01 |
| 2010-12-31 | $87.07M | -7.7% | 2013-03-06, From 2010-01-01 |
| 2009-12-31 | $94.30M | +20.7% | 2012-03-02, From 2009-01-01 |
| 2008-12-31 | $78.12M | n/a | 2011-03-22, From 2008-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $229.34M | -69.0% |
| Incyte Corp (INCY) | 2025-12-31 | $1.29B | n/m |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $1.36B | -0.9% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | -$142.16M | n/m |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $451.12M | +11.6% |
| NRC Health (NRC) | 2025-12-31 | $11.60M | -53.2% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$44.63M | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$64.78M | n/m |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | -$12.43M | n/m |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗